BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 2021. [PMID: 34050894 DOI: 10.1007/s13238-021-00846-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu S, Lu T, Shang J, Cai Y, Ding M, Zhou X, Wang X. PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell Death Discov 2023;9:39. [PMID: 36725845 DOI: 10.1038/s41420-023-01311-6] [Reference Citation Analysis]
2 Cao X, Jin X, Zhang X, Utsav P, Zhang Y, Guo R, Lu W, Zhao M. Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Curr Treat Options Oncol 2023. [PMID: 36701037 DOI: 10.1007/s11864-023-01049-4] [Reference Citation Analysis]
3 Wang JH, Mao L, Wang J, Zhang X, Wu M, Wen Q, Yu SC. Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination. Cell Oncol (Dordr) 2023. [PMID: 36656507 DOI: 10.1007/s13402-023-00775-z] [Reference Citation Analysis]
4 Zeng H, Lu X, Sun H, Wang H. Editorial: Epigenetics of metabolism, immunology and aging. Front Genet 2023;14:1135889. [PMID: 36741313 DOI: 10.3389/fgene.2023.1135889] [Reference Citation Analysis]
5 Hong H, Chen X, Wang H, Gu X, Yuan Y, Zhang Z. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma. Proteomics 2023;:e2200432. [PMID: 36625413 DOI: 10.1002/pmic.202200432] [Reference Citation Analysis]
6 Liu WJ, Zhao Y, Chen X, Miao ML, Zhang RQ. Epigenetic modifications in esophageal cancer: An evolving biomarker. Front Genet 2022;13:1087479. [PMID: 36704345 DOI: 10.3389/fgene.2022.1087479] [Reference Citation Analysis]
7 Li Y, Wu C, Ge Y, Chen X, Zhu L, Chu L, Wang J, Yan M, Deng H. Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma. Front Genet 2022;13:1089291. [PMID: 36685912 DOI: 10.3389/fgene.2022.1089291] [Reference Citation Analysis]
8 Deng Y, Ma J, Zhao S, Yang M, Sun Y, Zhang Q. Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months. Transl Oncol 2023;28:101614. [PMID: 36584488 DOI: 10.1016/j.tranon.2022.101614] [Reference Citation Analysis]
9 Li Y, Mo H, Jia S, Wang J, Ma Y, Liu X, Tu K. Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma. Front Immunol 2022;13:1066773. [PMID: 36582227 DOI: 10.3389/fimmu.2022.1066773] [Reference Citation Analysis]
10 Zhou Z, Fan B, Cheng H, Wang M, Xie J, Zou M, Yang Y. A Systematic Analysis of the Role of Unc-5 Netrin Receptor A (UNC5A) in Human Cancers. Biomolecules 2022;12. [PMID: 36551254 DOI: 10.3390/biom12121826] [Reference Citation Analysis]
11 Zhu M, Liu N, Lin J, Wang J, Lai H, Liu Y. HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer. Oncol Lett 2023;25:33. [PMID: 36589669 DOI: 10.3892/ol.2022.13619] [Reference Citation Analysis]
12 Granit A, Mishra K, Barasch D, Peretz-Yablonsky T, Eyal S, Kakhlon O. Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin. Front Cell Dev Biol 2022;10:1014798. [PMID: 36544904 DOI: 10.3389/fcell.2022.1014798] [Reference Citation Analysis]
13 Recillas-Targa F. Cancer Epigenetics: An Overview. Arch Med Res 2022;53:732-40. [PMID: 36411173 DOI: 10.1016/j.arcmed.2022.11.003] [Reference Citation Analysis]
14 Zhang S, Meng Y, Zhou L, Qiu L, Wang H, Su D, Zhang B, Chan K, Han J. Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. MedComm 2022;3. [DOI: 10.1002/mco2.173] [Reference Citation Analysis]
15 Wu Q, Gao Z, Yu X, Wang P. Dietary regulation in health and disease. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-01104-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Zhu L, Zheng W, Gao Q, Chen T, Pan Z, Cui W, Cai M, Fang H. Epigenetics and genetics of hepatoblastoma: Linkage and treatment. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1070971] [Reference Citation Analysis]
17 Wu C, Liu Y, Liu W, Zou T, Lu S, Zhu C, He L, Chen J, Fang L, Zou L, Wang P, Fan L, Wang H, You H, Chen J, Fang JY, Jiang C, Shi Y. NNMT-DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition. Adv Sci (Weinh) 2022;10:e2202642. [PMID: 36382559 DOI: 10.1002/advs.202202642] [Reference Citation Analysis]
18 Lin G, Huang T, Zhang X, Wang G. Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis. Cell Death Discov 2022;8:453. [DOI: 10.1038/s41420-022-01231-x] [Reference Citation Analysis]
19 Feng F, Pan L, Wu J, Liu M, He L, Yang L, Zhou W. Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1019486] [Reference Citation Analysis]
20 Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, Wei P, Li D. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol 2022;15:160. [PMID: 36319992 DOI: 10.1186/s13045-022-01358-5] [Reference Citation Analysis]
21 Rodriguez D, Fiengo L, Alvarez-kuglen M, Qin H, Farhy C, Havas A, Anderson RM, Adams PD, Sharpee TO, Terskikh AV. Microscopic Imaging of Epigenetic Age.. [DOI: 10.1101/2022.10.16.512441] [Reference Citation Analysis]
22 Liu Z, Yang H, Chen Z, Jing C. A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients. Hereditas 2022;159:40. [PMID: 36253800 DOI: 10.1186/s41065-022-00253-w] [Reference Citation Analysis]
23 Lin Y, Zhou X, Ni Y, Zhao X, Liang X. Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy. Front Immunol 2022;13:1030831. [DOI: 10.3389/fimmu.2022.1030831] [Reference Citation Analysis]
24 Liu X, Zhang Y, Li W, Zhou X. Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges. Front Cell Dev Biol 2022;10:972020. [DOI: 10.3389/fcell.2022.972020] [Reference Citation Analysis]
25 Meng Q, Zhang Y, Hao S, Sun H, Liu B, Zhou H, Wang Y, Xu Z. Recent findings in the regulation of G6PD and its role in diseases. Front Pharmacol 2022;13:932154. [DOI: 10.3389/fphar.2022.932154] [Reference Citation Analysis]
26 Brandão AS, Borbinha J, Pereira T, Brito PH, Lourenço R, Bensimon-brito A, Jacinto A. A regeneration-triggered metabolic adaptation is necessary for cell identity transitions and cell cycle re-entry to support blastema formation and bone regeneration. eLife 2022;11:e76987. [DOI: 10.7554/elife.76987] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Liu Y, Chen C, Wang X, Sun Y, Zhang J, Chen J, Shi Y. An Epigenetic Role of Mitochondria in Cancer. Cells 2022;11:2518. [PMID: 36010594 DOI: 10.3390/cells11162518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
28 Zara V, Assalve G, Ferramosca A. Multiple roles played by the mitochondrial citrate carrier in cellular metabolism and physiology. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04466-0] [Reference Citation Analysis]
29 Kajimura T, Serna VA, Amurgis E, Blumenfeld M, Kurita T. Patient-derived xenograft studies of fumarate hydratase (FH)-deficient uterine leiomyoma subtype.. [DOI: 10.1101/2022.07.27.501688] [Reference Citation Analysis]
30 Zhou X, Kandalai S, Hossain F, Zheng Q. Tumor microbiome metabolism: A game changer in cancer development and therapy. Front Oncol 2022;12:933407. [DOI: 10.3389/fonc.2022.933407] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Li Y, Liu B, Yin X, Jiang Z, Fang C, Chen N, Zhang B, Dai L, Yin Y. Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression. Clin Epigenetics 2022;14:92. [PMID: 35858918 DOI: 10.1186/s13148-022-01308-5] [Reference Citation Analysis]
32 Jiang F, Luo F, Zeng N, Mao Y, Tang X, Wang J, Hu Y, Wu C. Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients. Front Immunol 2022;13:902143. [DOI: 10.3389/fimmu.2022.902143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wang Y, Shen N, Spurlin G, Korm S, Huang S, Anderson NM, Huiting LN, Liu H, Feng H. α-Ketoglutarate-Mediated DNA Demethylation Sustains T-Acute Lymphoblastic Leukemia upon TCA Cycle Targeting. Cancers (Basel) 2022;14:2983. [PMID: 35740646 DOI: 10.3390/cancers14122983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
34 Zhang C, Zhu N, Li H, Gong Y, Gu J, Shi Y, Liao D, Wang W, Dai A, Qin L. New dawn for cancer cell death: Emerging role of lipid metabolism. Mol Metab 2022;63:101529. [PMID: 35714911 DOI: 10.1016/j.molmet.2022.101529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Yang G, Shan D, Zhao R, Li G. Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy. Front Cell Dev Biol 2022;10:902298. [DOI: 10.3389/fcell.2022.902298] [Reference Citation Analysis]
36 Lacombe V, Lenaers G, Urbanski G. Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers. Nutrients 2022;14:2058. [DOI: 10.3390/nu14102058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Allen CNS, Santerre M, Arjona SP, Ghaleb LJ, Herzi M, Llewellyn MD, Shcherbik N, Sawaya BE. SARS-CoV-2 Causes Lung Inflammation through Metabolic Reprogramming and RAGE. Viruses 2022;14:983. [DOI: 10.3390/v14050983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wei D, Xu M, Wang Z, Tong J. The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties. Front Oncol 2021;11:814085. [PMID: 35083160 DOI: 10.3389/fonc.2021.814085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Brandão AS, Borbinha J, Pereira T, Brito PH, Lourenço R, Bensimon-brito A, Jacinto A. Zebrafish caudal fin amputation induces a metabolic switch necessary for cell identity transitions and cell cycle re-entry to support blastema formation and bone regeneration.. [DOI: 10.1101/2022.01.26.477895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Adeshakin AO, Adeshakin FO, Yan D, Wan X. Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy. Front Immunol 2022;13:781660. [DOI: 10.3389/fimmu.2022.781660] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
41 Huo M, Zhang J, Huang W, Wang Y. Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer. Front Cell Dev Biol 2021;9:793428. [PMID: 35004688 DOI: 10.3389/fcell.2021.793428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
42 Wang G, Han JJ. Connections between metabolism and epigenetic modifications in cancer. Medical Review 2021;1:199-221. [DOI: 10.1515/mr-2021-0015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Zhang Y, Liang X, Zhang L, Wang D. DNA Methylation Modification Regulator-Mediated Molecular Clusters and Tumor Metabolic Characterization in Prostate Cancer. J Oncol 2021;2021:2408637. [PMID: 34804158 DOI: 10.1155/2021/2408637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Bonanomi M, Salmistraro N, Fiscon G, Conte F, Paci P, Bravatà V, Forte GI, Volpari T, Scorza M, Mastroianni F, D'Errico S, Avolio E, Piccialli G, Colangelo AM, Vanoni M, Gaglio D, Alberghina L. Transcriptomics and Metabolomics Integration Reveals Redox-Dependent Metabolic Rewiring in Breast Cancer Cells. Cancers (Basel) 2021;13:5058. [PMID: 34680207 DOI: 10.3390/cancers13205058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Bandyopadhaya A, Singh VK, Chakraborty A, Tzika AA, Rahme LG. Immunometabolic hijacking of immune cells by a Pseudomonas aeruginosa quorum-sensing signal.. [DOI: 10.1101/2021.10.03.462785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zhang W, Tan X, Lin S, Gou Y, Han C, Zhang C, Ning W, Wang C, Xue Y. CPLM 4.0: an updated database with rich annotations for protein lysine modifications. Nucleic Acids Res 2021:gkab849. [PMID: 34581824 DOI: 10.1093/nar/gkab849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Zhang X, Dong Z, Cui H. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer. Biomolecules 2021;11:1406. [PMID: 34680038 DOI: 10.3390/biom11101406] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Guo W, Li C. Linking Cellular Metabolism to Epigenetics in Melanoma. Int J Dermatol Venereol 2021;4:168-173. [DOI: 10.1097/jd9.0000000000000191] [Reference Citation Analysis]
49 Giuliano M, Pellerito C, Celesia A, Fiore T, Emanuele S. Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells. Molecules 2021;26:5010. [PMID: 34443600 DOI: 10.3390/molecules26165010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Bhingarkar A, Vangapandu HV, Rathod S, Hoshitsuki K, Fernandez CA. Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias. Front Oncol 2021;11:694526. [PMID: 34277440 DOI: 10.3389/fonc.2021.694526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]